Literature DB >> 10845139

Preparing your patients to travel abroad safely. Part 3: Reducing the risk of malaria and dengue fever.

R E Thomas1.   

Abstract

OBJECTIVE: To provide evidence-based recommendations for family physicians advising travelers on how to reduce their risk of malaria and dengue fever. QUALITY OF EVIDENCE: A search of MEDLINE from 1990 to November 1998 found 671 articles; randomized controlled trials and systematic reviews were sought. The Cochrane Collaboration was searched for studies relevant to family physicians; meta-analyses of impregnating bed nets with permethrin were found. Health Canada's evidence-based publications were searched; 10 recommendations based on at least one well-conducted randomized trial were found. MAIN MESSAGE: Good evidence-based advice about the efficacy of mefloquine in chloroquine-resistant areas and for pregnant women and children is available, as is advice on the effectiveness of permethrin-impregnated bed nets.
CONCLUSIONS: Family physicians can use evidence-based recommendations to advise their patients on how to prevent malaria. The ways in which patients neglect malaria precautions are well-known. For prevention of both malaria and dengue fever, family physicians should counsel their patients to reduce the risk of being bitten by insects.

Entities:  

Mesh:

Year:  2000        PMID: 10845139      PMCID: PMC2144887     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  10 in total

1.  Tolerance of mefloquine by SwissAir trainee pilots.

Authors:  P Schlagenhauf; H Lobel; R Steffen; R Johnson; K Popp; A Tschopp; R Letz; C Crevoisier
Journal:  Am J Trop Med Hyg       Date:  1997-02       Impact factor: 2.345

2.  Insecticide-treated bed nets in control of malaria in Africa.

Authors:  R W Snow; C Lengeler; D de Savigny; J Cattani
Journal:  Lancet       Date:  1995-04-22       Impact factor: 79.321

Review 3.  Diagnosis and treatment of malaria in Britain.

Authors:  M Molyneux; R Fox
Journal:  BMJ       Date:  1993-05-01

4.  Mefloquine tolerability during chemoprophylaxis: focus on adverse event assessments, stereochemistry and compliance.

Authors:  P Schlagenhauf; R Steffen; H Lobel; R Johnson; R Letz; A Tschopp; N Vranjes; Y Bergqvist; O Ericsson; U Hellgren; L Rombo; S Mannino; J Handschin; D Stürchler
Journal:  Trop Med Int Health       Date:  1996-08       Impact factor: 2.622

Review 5.  Mefloquine to prevent malaria: a systematic review of trials.

Authors:  A Croft; P Garner
Journal:  BMJ       Date:  1997-11-29

6.  A trial of artemether or quinine in children with cerebral malaria.

Authors:  M B van Hensbroek; E Onyiorah; S Jaffar; G Schneider; A Palmer; J Frenkel; G Enwere; S Forck; A Nusmeijer; S Bennett; B Greenwood; D Kwiatkowski
Journal:  N Engl J Med       Date:  1996-07-11       Impact factor: 91.245

7.  Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.

Authors:  R Steffen; E Fuchs; J Schildknecht; U Naef; M Funk; P Schlagenhauf; P Phillips-Howard; C Nevill; D Stürchler
Journal:  Lancet       Date:  1993-05-22       Impact factor: 79.321

Review 8.  Malaria in travellers: epidemiology and prevention.

Authors:  R H Behrens; C F Curtis
Journal:  Br Med Bull       Date:  1993-04       Impact factor: 4.291

9.  Long-term malaria prophylaxis with weekly mefloquine.

Authors:  H O Lobel; M Miani; T Eng; K W Bernard; A W Hightower; C C Campbell
Journal:  Lancet       Date:  1993-04-03       Impact factor: 79.321

10.  Prevalence of infection with dengue virus among international travelers.

Authors:  T Jelinek; G Dobler; M Hölscher; T Löscher; H D Nothdurft
Journal:  Arch Intern Med       Date:  1997-11-10
  10 in total
  1 in total

1.  Travel-related health problems of Hong Kong residents: Assessing the need for travel medicine services.

Authors:  Abu Saleh M Abdullah; Davidson H Hamer
Journal:  Travel Med Infect Dis       Date:  2006-02-17       Impact factor: 6.211

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.